Cytokeratin Expression in Hepatocellular Carcinoma: an Immunohistochemical Study
Overview
Affiliations
Normal human hepatocytes express cytokeratins no. 8 and 18, whereas bile duct cells contain the same cytokeratins and, in addition, cytokeratins no. 7 and 19. This cytokeratin pattern is believed to be preserved during neoplastic transformation. Thirty-four cases of hepatocellular carcinoma (11 well differentiated, 16 moderately differentiated, 7 poorly differentiated) were studied on frozen sections using monoclonal antisera directed against individual cytokeratins no. 7, 8, 18, and 19 in an immunoperoxidase procedure. In 17 of 34 cases, tumor cells showed only reactivity with monoclonals anticytokeratin no. 8 and 18. However, 17 of 34 cases showed an aberrant pattern in that a variable number of tumor cells were stained with anticytokeratins no. 7 and/or 19 in addition to no. 8 and 18. Only three of 11 well-differentiated cases displayed an unexpected cytokeratin pattern, whereas an aberrant pattern was present in all seven of seven poorly differentiated cases. These results are in conflict with previously published data obtained by two-dimensional gel electrophoresis and immunohistochemistry. They indicate that the cytokeratin pattern might not always be preserved during neoplastic transformation. The implication of this finding for the differential diagnosis of metastatic gastrointestinal carcinomas is discussed.
Unusual or Uncommon Histology of Gastric Cancer.
Shin J, Park Y J Gastric Cancer. 2024; 24(1):69-88.
PMID: 38225767 PMC: 10774758. DOI: 10.5230/jgc.2024.24.e7.
Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors.
Menz A, Gorbokon N, Viehweger F, Lennartz M, Hube-Magg C, Hornsteiner L Int J Surg Pathol. 2022; 31(6):927-938.
PMID: 35946088 PMC: 10492441. DOI: 10.1177/10668969221117243.
Heterogeneity of antigenic constellation in human hepatocellular carcinoma.
Ceausu M, Socea B, Serban D, Smarandache C, Predescu D, Bacalbasa N Exp Ther Med. 2021; 21(3):270.
PMID: 33603877 PMC: 7851646. DOI: 10.3892/etm.2021.9701.
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma.
Kaseb A, Hassan M, Lacin S, Abdel-Wahab R, Amin H, Shalaby A Oncotarget. 2016; 7(43):69916-69926.
PMID: 27655712 PMC: 5342524. DOI: 10.18632/oncotarget.12066.
Moreira A, Rodrigues G, Bona S, Fratta L, Weber G, Picada J Protoplasma. 2016; 254(2):911-920.
PMID: 27525410 DOI: 10.1007/s00709-016-1000-0.